Medical Sciences Webinar | Corticosteroids in Community-Acquired Pneumonia (CAP), 17 December 2025
Welcome message from the Chair:
Welcome to the Corticosteroid’s webinar organized by the ournal of Medical Sciences (ISSN: 2076-3271). This webinar will cover controversial topics such as the administration of corticosteroids in sCAP, a frequent respiratory infection and a very lethal disease.
After a short introduction by myself, Prof. Marco Confalonieri from Triestre will review the complex issue of the physiology of corticosteroids administration in critically ill patients, and Prof. François-Dequin from Tour will provide an in-depth review on the current evidence, including the pros and the cons, for administering corticosteroids in sCAP.
Following the two presentations, there will be a debate and a Q&A session with our two speakers.
Date: 17 12 2025 at 5:00 p.m. CET | 11:00 a.m. EST
Webinar ID: 836 7053 6137
Register now for free!
Program:
| Speaker/Presentation | Time in CET | Time in EST |
| Prof. Dr. Antoni Torres Chair Introduction |
5:00–5:05 p.m. | 11:00–11:05 a.m. |
| Prof. Dr. Marco Confalonieri | 5:05–5:25 p.m. | 11:05–11:25 a.m. |
| Prof. Dr. Pierre François Dequin | 5:25–5:45 p.m. | 11:25–11:45 a.m. |
| Q&A Session | 5:25–6:00 p.m. | 11:45 a.m.–12:00 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Prof. Dr. Antoni Torres, 1 Institut D investigacions August Pi I Sunyer (IDIBAPS), Department of Pulmonology, Hospital Clinic de Barcelona, Universidad de Barcelona, 08036 Barcelona, Spain; 2 Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain;
- Prof. Dr. Marco Confalonieri, Department of Pulmonology, University of Trieste, Italy;
- Prof. Dr. Pierre François Dequin, Department of Intensive Care Medicine, University of Tours, France.